Competent Cells Market Size, Share, Trends, Technology By 2023 Ready to Grow at 51.9%

The global competent cells market will grow at a CAGR of 10% from 2018 to 2023 to reach USD 2,318.6 million by 2023, according to this latest publication from Meticulous Research®. The global competent cells market is driven by various factors such as growing demand for recombinant proteins & molecular cloned products, advancement in molecular cloning research with emergence of new technologies, and rising government initiatives and funding for life science research.

Key Opportunities and Challenges for the Competent cells Market
Emerging economies such as Latin America, Asia Pacific, & Africa provides significant opportunities for various stakeholders in this market. However, increasing recombinational and cloning based applications simultaneously enhance the need for maintenance of laboratory transformation parameters; thereby challenging the growth of competent cells market to some extent.

Key Topics Covered in This Report:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Insights
5. Competent Cells Market, by Type
6. Competent Cells Market, by Treatment
7. Competent Cells Market, by Application
8. Competent Cells Market, by End-User
9. Competent Cells Market, by Geography

Browse in-depth Report on :https://www.meticulousresearch.com/product/competent-cells-market-forecast-2023/

Key Market Segments to Watch

The global competent cells market is mainly categorized by type (cloned competent cells, Agrobacterium tumefaciens competent cells, expression competent cells), treatment (chemically competent cells and electrocompetent cells), application (cloning, protein expression, others), end user (pharmaceutical & biotechnology industry, academics & research institutes, and contract research organizations), and geography.

On the basis of type, cloned competent cells commanded the largest share in the global competent cells market in 2017, mainly due to their rising adoption in research with increasing feasibility of genetic therapy, need for rapid diagnosis & treatment, favorable government support for cloning based research in various countries, and rising availability of sophisticated instruments and technology.

On the basis of treatment, chemically competent cells held the largest share in the global competent cells market in 2017. This was mainly attributed to the rising need for cost effective experimental protocol with growing demand for recombinant proteins and molecular cloned products, and rising intensity of cell based research. Chemically competent cells have been commonly used for transformation and vector based molecular cloning experiments because the treatment of competent cells through chemicals is very simple, faster, cost effective, and does not require any specialized equipment.

On the basis of application, cloning accounted for the largest share in the global competent cells market in 2017. The large share of this market is mainly attributed to various advancements in recombinant technology, increasing government support for cloning based research, and rising R&D funding for cell based research.

Based on end user, pharmaceutical and biotechnology industry commanded the largest share in the global competent cells market in 2017, mainly due to higher adoption of competent cells by pharmaceutical & biotechnology companies with growing demand for molecular cloning with advancements in the cloning technologies, and rising investments in research & development to fulfill the demand for protein based therapeutics.

Key players in the global market

The key players in the global competent cells market are Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck & Company, Inc., Illumina, Inc., Promega Corporation, New England Biolabs, OriGene Technologies, Inc., Zymo Research Corporation, Scarab Genomics, LLC, Meridian Bioscience, Inc., Delphi Genetics S.A., Qiagen N.V., Cell Applications, Inc., GenScript Biotech Corporation, and Takara Holdings Inc.

Download Sample: https://www.meticulousresearch.com/download-sample-report/?cp_id=3723

Contact Us:
Khushal
Tel: +1-646-781-8004
Email: sales@meticulousresearch.com

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

Asia-Pacific

Office No-202, 203,204,205,206; 2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad, 411057 India.

This release was published on openPR.